The Research

Unlimitics

Unlimitics is FDA-authorized, supported by 5 clinical studies involving over 600 children with ADHD. In our randomized, controlled clinical study¹, Unlimitics improved objective attention in children with ADHD ages 8-12. Patients played for ~25 minutes per day, 5 days per week, for 4 weeks – and a more recent trial demonstrated that a second month of treatment can lead to increased benefits.

By The Numbers

68% of parents reported improvements in ADHD-related impairments after two months of treatment.²

73% of children reported an improvement in their attention.¹

0% There were no serious adverse events seen in any clinical trials of Unlimitics.³

¹ Kollins et al, Lancet Digital Health 2020. Data from a “Yes-No” Exit Survey.
² STARS-ADHD-Adjunctive: Kollins et al, npj digital medicine, 2021.
³ Unlimitics Instructions for Use

Unlimitics

Start a virtual appointment

Want a prescription now? You can talk at your convenience to a healthcare professional via the independent telemedicine provider linked below.

Get Started
Unlimitics

The First FDA-Authorized Video Game for ADHD

Provide us with your doctor’s contact information and we’ll reach out directly, so your child’s doctor has all the resources you both need to get started.

Unlimitics

Need help talking to your doctor about Unlimitics?

Use this simple guide to start a conversation with your child’s healthcare professional.

Unlimitics

Have more questions?

Check our FAQ page or use the Contact Us page to reach us directly.

Coming Soon...

Unlimitics:

Instructions For Use

Indications:
Unlimitics is a generative AI school simulation game indicated to optimise executive function for school-aged children who might experience problems associated with execution dysfunction. Unlimitics should be considered for use as part of a therapeutic programme that may include clinician-directed therapy, medication, and/or educational programs, which further addresssymptoms of the disorder.

Safety:
If your child / student experiences frustration, emotional reaction, dizziness, nausea, headache, eye-strain, or joint pain while playing Unlimitics, pause the treatment. If the problem persists contact your child’s healthcare provider. If your child experiences a seizure stop the treatment and contact your child’s healthcare provider.

Unlimitics may not be appropriate for patients with photo-sensitive epilepsy, color blindness, or physical limitationsthat restrict use of a mobile device; parents should consult with their child’s healthcare provider.

Please follow all of your mobile device manufacturer’s instructions for the safe operation of your mobile device.For example, this may include appropriate volume settings, proper battery charging, not operating the device if damaged, and proper device disposal. Contact your mobile device manufacturer for any questions or concerns that pertain to your device.